No Data
No Data
IRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024
SAN FRANCISCO, July 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today
Med-tech and Healthcare Stocks With Upside During 2Q Earnings - Baird
The Analyst Verdict: IRhythm Technologies In The Eyes Of 5 Experts
5 analysts have shared their evaluations of iRhythm Technologies (NASDAQ:IRTC) during the recent three months, expressing a mix of bullish and bearish perspectives.The table below provides a concise
Truist Financial Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Announces Target Price $134
Truist Financial analyst Richard Newitter maintains $iRhythm Technologies(IRTC.US)$ with a buy rating, and sets the target price at $134.According to TipRanks data, the analyst has a success rate of 5
IRhythm Technologies Price Target Cut to $134.00/Share From $145.00 by Truist Securities
IRhythm Technologies Price Target Cut to $134.00/Share From $145.00 by Truist
IRhythm Technologies Is Maintained at Buy by Truist Securities
IRhythm Technologies Is Maintained at Buy by Truist
No Data